These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20712013)

  • 1. Lung carcinoma with rhabdoid component. A series of seven cases associated with uncommon types of non-small cell lung carcinomas and alveolar entrapment.
    Izquierdo-Garcia FM; Moreno-Mata N; Herranz-Aladro ML; Cañizares MA; Alvarez-Fernandez E
    Histol Histopathol; 2010 Oct; 25(10):1287-95. PubMed ID: 20712013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined large cell neuroendocrine, small cell and squamous carcinomas of the lung with rhabdoid cells.
    Chetty R
    Pathology; 2000 Aug; 32(3):209-12. PubMed ID: 10968398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prognostic value of cytokeratin 19 expression in non-small cell lung cancer].
    Kosacka M; Jankowska R
    Pneumonol Alergol Pol; 2007; 75(4):317-23. PubMed ID: 18080980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma.
    Ritter JH; Dresler CM; Wick MR
    Hum Pathol; 1995 Nov; 26(11):1227-32. PubMed ID: 7590697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
    Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
    Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
    J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
    Argon A; Nart D; Veral A
    Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
    Volm M; Koomägi R
    Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology.
    Anagnostou VK; Lowery FJ; Zolota V; Tzelepi V; Gopinath A; Liceaga C; Panagopoulos N; Frangia K; Tanoue L; Boffa D; Gettinger S; Detterbeck F; Homer RJ; Dougenis D; Rimm DL; Syrigos KN
    BMC Cancer; 2010 May; 10():186. PubMed ID: 20459695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer.
    Ramnath N; Hernandez FJ; Tan DF; Huberman JA; Natarajan N; Beck AF; Hyland A; Todorov IT; Brooks JS; Bepler G
    J Clin Oncol; 2001 Nov; 19(22):4259-66. PubMed ID: 11709570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undifferentiated large cell/rhabdoid carcinoma presenting in the intestines of patients with concurrent or recent non-small cell lung cancer (NSCLC): clinicopathologic and molecular analysis of 14 cases indicates an unusual pattern of dedifferentiated metastases.
    Agaimy A; Daum O; Michal M; Schmidt MW; Stoehr R; Hartmann A; Lauwers GY
    Virchows Arch; 2021 Jul; 479(1):157-167. PubMed ID: 33506327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma of lung with rhabdoid features.
    Tamboli P; Toprani TH; Amin MB; Ro JS; Ordóñez NG; Ayala AG; Ro JY
    Hum Pathol; 2004 Jan; 35(1):8-13. PubMed ID: 14745719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
    Yaman B; Nart D; Ekren PK; Çok G; Veral A
    Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult renal cell carcinoma with rhabdoid differentiation: incidence and clinicopathologic features in Chinese patients.
    Yang X; Xi C; Jin J; Zhou L; Su J; Liu L; Liu Y
    Ann Diagn Pathol; 2015 Apr; 19(2):57-63. PubMed ID: 25708024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhabdoid large cell carcinoma of lung, with illustrative immunohistochemical and molecular findings.
    Dettmer M; Hench J; Pang B; Willi N; Cathomas G
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):208-13. PubMed ID: 22505007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
    Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
    Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites.
    Mitselou A; Batistatou A; Nakanishi Y; Hirohashi S; Vougiouklakis T; Charalabopoulos K
    Histol Histopathol; 2010 Oct; 25(10):1257-67. PubMed ID: 20712010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical significance of p53 protein and p21(WAF1) in non-small-cell lung carcinoma].
    Zhang H; Lü F; Yue W; Yan H; Deng L; Wang S
    Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):328-30. PubMed ID: 11866928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of human lung cancer/SCID mouse tumor xenografts and cell culture growth with patient clinical outcomes.
    Anderson TM; Hess SD; Egilmez NK; Nwogu CE; Lenox JM; Bankert RB
    J Cancer Res Clin Oncol; 2003 Oct; 129(10):565-8. PubMed ID: 12923636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.